Heron Therapeutics

This phase 2 trial tested two experimental drugs, HTX-011 and HTX-002, for pain relief after abdominoplasty (tummy tuck) surgery. 277 adults received an injection of the drug or a placebo. The main goal was to measure pain intensity over the first 24 hours. The study is now compl…

This study tested whether a non-opioid pain regimen, including a long-acting numbing shot (HTX-011) and standard pain relievers like ibuprofen and acetaminophen, could help people avoid opioids after hernia surgery. About 209 adults scheduled for open inguinal hernia repair took …

This study tested a drug called HTX-011, which combines two pain relievers (bupivacaine and meloxicam), given as a nerve block before breast augmentation surgery. The goal was to see if it reduces pain and the need for opioid painkillers after the operation. The trial involved 24…

This study tested an experimental pain medication called HTX-011 in 430 adults recovering from bunion surgery. The goal was to see if it reduces pain better than standard treatments. Participants received the drug locally at the surgery site, and pain levels were tracked for 24 h…

This study tested a new drug called APF530, given with dexamethasone, to see if it could prevent nausea and vomiting caused by chemotherapy. Over 1,400 adults with cancer took part. The goal was to see if APF530 worked as well as or better than the standard drug palonosetron.

This study tested three different pain-relief drugs (HTX-011, HTX-002, HTX-009) in 463 adults after open hernia surgery. Participants rated their pain over 24 hours to see how well each drug worked. The goal was to find a safe and effective way to manage pain after this common su…

This study tested a new non-opioid pain medicine called HTX-011 in 116 people having knee replacement surgery. Everyone received the medicine as part of a pain plan that did not include opioids. The goal was to see how well it controlled pain after surgery. The study is complete,…

This study tested whether a new drug called APF530 (given as a shot under the skin) works better than the standard drug ondansetron (given through an IV) at preventing nausea and vomiting in the days after chemotherapy. About 942 adults with cancer receiving strong chemotherapy t…

This study tested a new long-acting painkiller called HTX-011 in 418 adults having hernia surgery. The goal was to see if it reduces pain and the need for opioid pain pills after the operation. Participants received either the study drug, a standard painkiller, or a placebo to co…

This study tested a new pain-relieving medicine called HTX-011 in 285 people having knee replacement surgery. The medicine was injected into the surgical area to see if it could reduce pain and the need for strong opioid painkillers. The goal was to find a safer, more effective w…